1. Home
  2. ECOR vs TELO Comparison

ECOR vs TELO Comparison

Compare ECOR & TELO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ECOR
  • TELO
  • Stock Information
  • Founded
  • ECOR 2005
  • TELO 2021
  • Country
  • ECOR United States
  • TELO United States
  • Employees
  • ECOR N/A
  • TELO N/A
  • Industry
  • ECOR Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • TELO
  • Sector
  • ECOR Health Care
  • TELO
  • Exchange
  • ECOR Nasdaq
  • TELO NYSE
  • Market Cap
  • ECOR 50.1M
  • TELO 52.4M
  • IPO Year
  • ECOR 2018
  • TELO 2024
  • Fundamental
  • Price
  • ECOR $6.11
  • TELO $1.15
  • Analyst Decision
  • ECOR Strong Buy
  • TELO
  • Analyst Count
  • ECOR 2
  • TELO 0
  • Target Price
  • ECOR $25.50
  • TELO N/A
  • AVG Volume (30 Days)
  • ECOR 71.2K
  • TELO 474.7K
  • Earning Date
  • ECOR 08-06-2025
  • TELO 08-12-2025
  • Dividend Yield
  • ECOR N/A
  • TELO N/A
  • EPS Growth
  • ECOR N/A
  • TELO N/A
  • EPS
  • ECOR N/A
  • TELO N/A
  • Revenue
  • ECOR $26,458,000.00
  • TELO N/A
  • Revenue This Year
  • ECOR $23.21
  • TELO N/A
  • Revenue Next Year
  • ECOR $44.10
  • TELO N/A
  • P/E Ratio
  • ECOR N/A
  • TELO N/A
  • Revenue Growth
  • ECOR 41.54
  • TELO N/A
  • 52 Week Low
  • ECOR $4.47
  • TELO $1.15
  • 52 Week High
  • ECOR $19.49
  • TELO $8.40
  • Technical
  • Relative Strength Index (RSI)
  • ECOR 62.63
  • TELO 22.63
  • Support Level
  • ECOR $5.13
  • TELO $1.65
  • Resistance Level
  • ECOR $5.69
  • TELO $1.81
  • Average True Range (ATR)
  • ECOR 0.42
  • TELO 0.15
  • MACD
  • ECOR 0.09
  • TELO -0.05
  • Stochastic Oscillator
  • ECOR 91.27
  • TELO 0.00

About ECOR electroCore Inc.

electroCore Inc is a commercial stage bioelectronic medicine company with a platform for non-invasive vagus nerve stimulation therapy initially focused on neurology. The company's product gammaCore is Food and Drug Administration cleared in the United States for adjunctive use for the preventive treatment of cluster headache in adult patients, the acute treatment of pain associated with episodic cluster headache in adult patients, the acute treatment of pain associated with migraine headache in adult patients, and the prevention of migraine in adult patients, The use of gammaCore by adolescent patients and Treatment of hemicrania continua and paroxysmal hemicrania in adult patients.

About TELO TELOMIR PHARMACEUTICALS INC

Telomir Pharmaceuticals Inc is a pioneering preclinical-stage pharmaceutical company which leads the advancement of age-reversal science. The Company is focused on developing Telomir-1, a novel small molecule designed to lengthen and protect telomeres-the protective DNA end caps of chromosomes that are crucial to cellular aging. As humans and animals age, telomeres naturally shorten, with metal reactivity accelerating this process, increasing the risk of degenerative and age-related diseases. By addressing the underlying causes of aging at the cellular level, Telomir aims to tackle the root of these conditions rather than simply treating their symptoms. Telomir is conducting ongoing preclinical research into Progeria, diabetes, cancer, Alzheimer's disease, osteoarthritis, and others.

Share on Social Networks: